Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today reports 2021 second quarter financial results and provides a status update on the Companys development portfolio.
In the second quarter, we saw an acceleration of growth of Jakafi® (ruxolitinib)…

Click here to view the original article.

Business Wire, Global

Share this article

How States Are Taking Aim at Combating Crypto ATM Fraud

February 13, 2026

Bitcoin Price Prediction: $50K Support at Risk Amid Thailand Crypto Push

February 13, 2026

Boerse Stuttgart Digital, tradias plan merger to create EU crypto infra group – Ledger Insights

February 13, 2026

CVW Sustainable Royalties Announces $50 Million Strategic Investment by Fairfax and Upsize of Previously Announced Private Placement Financing to a Maximum of $50 Million for $100 Million in Total Financing

February 13, 2026

Boerse Stuttgart Digital, tradias Form European Crypto Champ

February 13, 2026

Investing in Primary Care: The Missing Strategy in America’s Fight Against Chronic Disease

February 13, 2026

Boerse Stuttgart Digital, Tradias agree merger to build European crypto hub — TradingView News

February 13, 2026

The Shipyard Makes Strategic Investment in FancyAI to Lead the Next Era of Brand Discovery

February 13, 2026